Woodline Partners »

Bright Minds Biosciences shares owned by Woodline Partners

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Woodline Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 46k 72.97

More positions owned by Woodline Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Revolution Medicines (RVMD)
Verizon Communications (VZ)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Applied Materials (AMAT)
Texas Instruments Incorporated (TXN)

View all positions for Woodline Partners

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences